| Zoledronic acid and clinical fractures and mortality after hip fracture KW Lyles, CS Colón-Emeric, JS Magaziner, JD Adachi, CF Pieper, ... New England Journal of Medicine 357 (18), 1799-1809, 2007 | 2513 | 2007 |
| Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis KG Saag, R Emkey, TJ Schnitzer, JP Brown, F Hawkins, S Goemaere, ... New England Journal of Medicine 339 (5), 292-299, 1998 | 1586 | 1998 |
| Romosozumab treatment in postmenopausal women with osteoporosis F Cosman, DB Crittenden, JD Adachi, N Binkley, E Czerwinski, S Ferrari, ... New England Journal of Medicine 375 (16), 1532-1543, 2016 | 1448 | 2016 |
| Risedronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women GA Wells, SC Hsieh, C Zheng, J Peterson, W Liu, SE Kelly, P Tugwell Cochrane database of systematic reviews, 2022 | 1029* | 2022 |
| Canadian normative data for the SF-36 health survey WM Hopman, T Towheed, T Anastassiades, A Tenenhouse, S Poliquin, ... Cmaj 163 (3), 265-271, 2000 | 972 | 2000 |
| Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis JD Adachi, WG Bensen, J Brown, D Hanley, A Hodsman, R Josse, ... New England Journal of Medicine 337 (6), 382-388, 1997 | 944 | 1997 |
| Efficacy of raloxifene on vertebral fracture risk reduction in postmenopausal women with osteoporosis: four-year results from a randomized clinical trial PD Delmas, KE Ensrud, JD Adachi, KD Harper, S Sarkar, C Gennari, ... The Journal of Clinical Endocrinology & Metabolism 87 (8), 3609-3617, 2002 | 777 | 2002 |
| Two‐year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: a randomized, double‐blind, placebo‐controlled extension trial JD Adachi, KG Saag, PD Delmas, UA Liberman, RD Emkey, E Seeman, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2001 | 718 | 2001 |
| Severity of prevalent vertebral fractures and the risk of subsequent vertebral and nonvertebral fractures: results from the MORE trial PD Delmas, HK Genant, GG Crans, JL Stock, M Wong, E Siris, JD Adachi Bone 33 (4), 522-532, 2003 | 659 | 2003 |
| Obesity is not protective against fracture in postmenopausal women: GLOW JE Compston, NB Watts, R Chapurlat, C Cooper, S Boonen, S Greenspan, ... The American journal of medicine 124 (11), 1043-1050, 2011 | 623 | 2011 |
| II. Meta-analysis of alendronate for the treatment of postmenopausal women ANN Cranney, G Wells, A Willan, L Griffith, N Zytaruk, V Robinson, ... Endocrine Reviews 23 (4), 508-516, 2002 | 553 | 2002 |
| Effect of selective serotonin reuptake inhibitors on the risk of fracture JB Richards, A Papaioannou, JD Adachi, L Joseph, HE Whitson, JC Prior, ... Archives of internal medicine 167 (2), 188-194, 2007 | 547 | 2007 |
| Relation between fractures and mortality: results from the Canadian Multicentre Osteoporosis Study G Ioannidis, A Papaioannou, WM Hopman, N Akhtar-Danesh, ... Cmaj 181 (5), 265-271, 2009 | 545 | 2009 |
| Economic implications of hip fracture: health service use, institutional care and cost in Canada ME Wiktorowicz, R Goeree, A Papaioannou, JD Adachi, ... Osteoporosis international 12, 271-278, 2001 | 541 | 2001 |
| III. Meta-analysis of risedronate for the treatment of postmenopausal osteoporosis A Cranney, P Tugwell, J Adachi, B Weaver, N Zytaruk, A Papaioannou, ... Endocrine Reviews 23 (4), 517-523, 2002 | 521* | 2002 |
| Quality of life issues in women with vertebral fractures due to osteoporosis DJ Cook, GH Guyatt, JD Adachi, J Clifton, LE Griffith, RS Epstein, ... Arthritis & Rheumatism: Official Journal of the American College of …, 1993 | 447 | 1993 |
| A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis S Lekamwasam, JD Adachi, D Agnusdei, J Bilezikian, S Boonen, ... Osteoporosis International 23, 2257-2276, 2012 | 442 | 2012 |
| The n-of-1 randomized controlled trial: clinical usefulness: our three-year experience GH Guyatt, JL Keller, R Jaeschke, D Rosenbloom, JD Adachi, ... Annals of internal medicine 112 (4), 293-299, 1990 | 428 | 1990 |
| The efficacy and tolerability of risedronate once a week for the treatment of postmenopausal osteoporosis. JP Brown, DL Kendler, MR McClung, RD Emkey, JD Adachi, ... Calcified Tissue International 71 (2), 2002 | 411 | 2002 |
| Frailty and sarcopenia: definitions and outcome parameters C Cooper, W Dere, W Evans, JA Kanis, R Rizzoli, AA Sayer, CC Sieber, ... Osteoporosis International 23, 1839-1848, 2012 | 406 | 2012 |
